Aladdin Healthcare Technologies SE announced that it has partnered with a China hardware technology company and co-developed a novel system which delivers an AI powered Body Temperature Screening System with the ability to offer mass health surveillance. Aladdin shares will also be traded on the XETRA electronic trading platform. In light of the COVID-19 pandemic which has a symptom of a fever at about 37.5 degrees Celsius, body temperature screening is a must for the prevention and control of not only COVID-19 but the majority of infectious diseases. Therefore, Aladdin and its partner, a hardware technology company based in China, have developed a novel system which delivers an AI powered body temperature screening system with the ability to offer mass health surveillance. The Thermo AI detection kit can detect temperatures in crowds without using a temperature gun and manually checking temperatures. The technology can detect temperatures from 16 people simultaneously. Aladdin will enhance the AI technology so that in the second quarter of 2020 an upgraded version of the application should be able to scale up to 200 people to be screened simultaneously. This system can be used in offices, hospitals, theatres, retailers, stadiums, museums and many other large capacity buildings. The product can be both tagged for identification or used with a de-identified option. Significantly, Aladdin will develop a zero-knowledge proof ID-system in 2020 so individuals can be identified whilst protecting the privacy of the individual. The technology will be branded under the Aladdin name and then licensed out to businesses. The company expects its first sale and installation of the product in April 2020.